Beigene (BGNE)

Trade BGNE now with
2/6/2023 6:40:26 AM BeiGene : Quebec Becomes First Province To Cover PrBRUKINSA For Treatment Of Waldenström's Macroglobulinemia
10/14/2022 6:34:01 AM BeiGene Gets Positive CHMP Opinion For BRUKINSA For Adults With Chronic Lymphocytic Leukemia
8/9/2022 6:05:19 AM BeiGene Says Phase 3 RATIONALE 301 Trial With Tislelizumab Meets Primary Endpoint
7/14/2022 6:24:50 AM Beigene Says FDA Defers Action On BLA For Tislelizumab
7/12/2022 7:01:50 AM Leap Therapeutics Begins New DKN-01 Clinical Trials In Gastric Cancer, Colorectal Cancer And Endometrial Cancer
6/21/2022 7:15:34 AM BeiGene: Center For Drug Evaluation Of China NMPA Accepts SBLA For Anti-PD-1 Inhibitor Tislelizumab
6/10/2022 7:14:28 AM BeiGene Presents Data From Hematology Portfolio At EHA 2022 Hybrid Congress
5/11/2022 11:57:56 AM BeiGene Stock Down 13%